about
Limitations of medical research and evidence at the patient-clinician encounter scaleA generalised model for individualising a treatment recommendation based on group-level evidence from randomised clinical trialsCost-effectiveness analysis and insurance coverage: solving a puzzle.Economic analysis of revision amputation and replantation treatment of finger amputation injuries.Cost-effectiveness analysis for cliniciansCost-effectiveness of a national exercise referral programme for primary care patients in Wales: results of a randomised controlled trialSelective decontamination of the digestive tract and selective oropharyngeal decontamination in intensive care unit patients: a cost-effectiveness analysis.Biases in Individualized Cost-effectiveness Analysis: Influence of Choices in Modeling Short-Term, Trial-Based, Mortality Risk Reduction and Post-Trial Life Expectancy.Costs and expected gain in lifetime health from intensive care versus general ward care of 30,712 individual patients: a distribution-weighted cost-effectiveness analysis.Multiomics medicine in oncology: assessing effectiveness, cost-effectiveness and future research priorities for the molecularly unique individual.Tolerance limits and tolerance intervals for ratios of normal random variables using a bootstrap calibration.HCV: the best cure possible or the best possible cure?Individualized cost-effectiveness analysis of patient-centered care: a case series of hospitalized patient preferences departing from practice-based guidelines.Qualitative process study to explore the perceived burdens and benefits of a digital intervention for self-managing high blood pressure in Primary Care in the UK.Predicting Therapy Success and Costs for Personalized Treatment Recommendations Using Baseline Characteristics: Data-Driven Analysis
P2860
Q24282606-C612D6D9-84B8-4ED5-B114-DF472F22CFEBQ30543580-2D514D7E-3160-4868-9FE4-4B7986A0E7A1Q33358138-E67F8160-F5DB-40DB-AC5A-6D83B8BEBA8CQ34131758-E2192952-8749-4A4D-85E9-212DCDE01B5AQ34148072-CDD3D3D8-AD37-47F7-9CB1-FFD2E89862B4Q34508518-4088D9EB-C2C6-4FCF-B262-CE5937B9750FQ36730251-F6973FA9-2C6A-4CA1-A172-B5E6DF20D1C7Q38602246-E4C10B84-2B80-412F-9339-F5EE86196899Q38613643-1969259A-E89D-4DD8-9D15-3F5AC7470140Q39352133-D044BFAA-7AC5-4925-A5BB-294E06B4986EQ40343233-FD6B3B85-172E-41B4-A5F5-32430FC5C575Q41621081-DE13DCB4-194F-4816-B9D1-BDFB665D9623Q50130718-8870B46A-374C-4153-9566-27BFE9920A5FQ53824247-E2D031BE-C93D-4435-B9B6-78BDA2742FCFQ58609557-42C31144-B8CD-44DE-971E-D7C23F835656
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Individualized cost-effectiveness analysis.
@ast
Individualized cost-effectiveness analysis.
@en
type
label
Individualized cost-effectiveness analysis.
@ast
Individualized cost-effectiveness analysis.
@en
prefLabel
Individualized cost-effectiveness analysis.
@ast
Individualized cost-effectiveness analysis.
@en
P2860
P1433
P1476
Individualized cost-effectiveness analysis.
@en
P2093
Alan M Garber
P2860
P304
P356
10.1371/JOURNAL.PMED.1001058
P407
P577
2011-07-12T00:00:00Z